ClinicalTrials.Veeva

Menu

Heart Rate Changes Following the Administration of Sugammadex

J

Joseph D. Tobias

Status

Completed

Conditions

Bradycardia

Treatments

Other: Recording heart rate changes

Study type

Observational

Funder types

Other

Identifiers

NCT03294018
IRB17-00540

Details and patient eligibility

About

This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decision is made to treat it, the medications and doses used will be recorded.

Enrollment

276 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient age 0-18 years
  • Anesthetic plan includes NMB reversal with sugammadex

Exclusion criteria

  • Sugammadex not used during the case

Trial design

276 participants in 1 patient group

Bradycardia during sugammadex administration
Description:
Recording any heart rate changes during planned administration of sugammadex.
Treatment:
Other: Recording heart rate changes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems